Work

Trial in progress: A phase two trial of nirogacestat, a gamma-secretase inhibitor, in patients with recurrent ovarian granulosa cell tumors (NCT05348356) (1284)

Year: 2023

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2023.06.190

Authors: Panagiotis Konstantinopoulos, Jocelyn Lewis, Todd Shearer, Heather Kaiser, Caroline Breitbach, Shinta Cheng

Institutions: Dana-Farber Cancer Institute, SpringWorks Therapeutics (United States)

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4386948049

FWCI: 0.719

Cites:

Cited by: 3

Related to: 10